Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Respiratory Monitoring (ORML) is a medical technology company specializing in the development of non-invasive respiratory monitoring devices. Spun out from the University of Oxford, the company focuses on its proprietary Pneumoscan technology, which utilizes inductive plethysmography to monitor breathing patterns without the need for masks or invasive sensors. Their primary application is in the diagnosis and management of sleep-disordered breathing, such as obstructive sleep apnea, and chronic respiratory conditions like COPD. The company's solutions aim to provide clinical-grade monitoring in both hospital and home-care settings, improving patient comfort and diagnostic accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Respiratory.